HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David Michelson Selected Research

Atomoxetine Hydrochloride (Strattera)

11/2008Long-term, open-label safety and efficacy of atomoxetine in adults with ADHD: final report of a 4-year study.
7/2008Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders.
6/2008Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response.
5/2008The reliability and validity of self- and investigator ratings of ADHD in adults.
9/2007High-dose atomoxetine treatment of ADHD in youths with limited response to standard doses.
3/2007A randomized, double-blind study of continuation treatment for attention-deficit/hyperactivity disorder after 1 year.
2/2007CYP2D6 and clinical response to atomoxetine in children and adolescents with ADHD.
12/2006Low-dose atomoxetine for maintenance treatment of attention-deficit/hyperactivity disorder.
3/2006Atomoxetine and adult attention-deficit/hyperactivity disorder: the effects of comorbidity.
3/2006Comorbid oppositional defiant disorder and the risk of relapse during 9 months of atomoxetine treatment for attention-deficit/hyperactivity disorder.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David Michelson Research Topics

Disease

28Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
07/2012 - 01/2002
15Sleep Initiation and Maintenance Disorders (Insomnia)
12/2021 - 05/2012
8Alzheimer Disease (Alzheimer's Disease)
12/2021 - 01/2018
7Migraine Disorders (Migraine)
01/2020 - 07/2012
7Pain (Aches)
01/2020 - 06/2005
4Dementia (Dementias)
12/2021 - 01/2018
4Seizures (Absence Seizure)
01/2020 - 04/2005
4Major Depressive Disorder (Major Depressive Disorders)
01/2017 - 03/2004
4Headache (Headaches)
08/2016 - 05/2012
3Sleepiness
01/2020 - 05/2014
3Schizophrenia (Dementia Praecox)
05/2013 - 07/2010
2Infections
01/2019 - 01/2016
2Parkinson Disease (Parkinson's Disease)
06/2017 - 12/2015
2Encephalitis (Encephalitis, Rasmussen)
04/2009 - 09/2006
2Brain Diseases (Brain Disorder)
09/2006 - 04/2005
2Oppositional Defiant Disorder
03/2006 - 03/2005
1Disease Progression
04/2019
1Multiple Sclerosis
01/2019
1Vaccine-Preventable Diseases
01/2019
1Latent Infection
01/2019
1Spinal Muscular Atrophy (Progressive Muscular Atrophy)
11/2018
1Wounds and Injuries (Trauma)
01/2018
1Diabetic Neuropathies (Diabetic Neuropathy)
01/2018
1Exanthema (Rash)
01/2018
1Weight Loss (Weight Reduction)
01/2018
1Coma (Comas)
01/2016
1Human Influenza (Influenza)
01/2016
1Constipation
12/2015
1Disorders of Excessive Somnolence (Hypersomnia)
10/2013
1Obstructive Sleep Apnea
10/2013
1Cognitive Dysfunction
05/2013
1Psychotic Disorders (Schizoaffective Disorder)
03/2013
1Anxiety Disorders (Anxiety Disorder)
02/2013
1Diarrhea
05/2012
1Spasm (Spasms)
05/2012
1Neuralgia (Stump Neuralgia)
03/2011
1Catatonia
07/2010
1Catatonic Schizophrenia
07/2010
1Treatment-Resistant Depressive Disorder
01/2010
1Amebiasis (Amoebiasis)
04/2009
1Alcoholism (Alcohol Abuse)
07/2008

Drug/Important Bio-Agent (IBA)

27Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric
11/2008 - 01/2002
14Orexin Receptor AntagonistsIBA
12/2021 - 12/2012
11suvorexantIBA
12/2021 - 12/2012
7Pharmaceutical PreparationsIBA
04/2019 - 01/2002
5verubecestatIBA
12/2020 - 01/2018
5Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA
03/2006 - 01/2003
4Calcitonin Gene-Related Peptide Receptor AntagonistsIBA
01/2020 - 09/2014
4MK-6096IBA
01/2018 - 04/2015
4Orexin ReceptorsIBA
01/2018 - 12/2012
4MK-0249IBA
10/2013 - 05/2012
4Norepinephrine (Noradrenaline)FDA LinkGeneric
06/2008 - 01/2003
3Antidepressive Agents (Antidepressants)IBA
01/2017 - 03/2004
3Methylphenidate (Ritalin)FDA LinkGeneric
07/2012 - 07/2002
2Phenobarbital (Luminal)FDA Link
01/2020 - 01/2016
2ubrogepantIBA
01/2020 - 08/2016
2VaccinesIBA
01/2019 - 09/2006
2Adenosine (Adenocard)FDA LinkGeneric
06/2017 - 12/2015
22- (2- furanyl)- 7- (2- (4- (4- (2- methoxyethoxy)phenyl)- 1- piperazinyl)ethyl)- 7H- pyrazolo(4,3- e)(1,2,4)triazolo(1,5- c)pyrimidine- 5- amineIBA
06/2017 - 12/2015
2telcagepantIBA
02/2016 - 09/2014
2Histamine (Histamine Dihydrochloride)FDA Link
05/2013 - 07/2012
2rizatriptan (Maxalt)FDA Link
01/2013 - 07/2012
2Analgesics (Analgesic Drugs)IBA
03/2011 - 06/2005
2Sertraline (Zoloft)FDA LinkGeneric
01/2009 - 04/2007
2Fluoxetine (Prozac)FDA LinkGeneric
09/2005 - 03/2004
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
11/2020
1lanabecestatIBA
11/2020
1Levetiracetam (Keppra)FDA LinkGeneric
01/2020
1Phenytoin (Dilantin)FDA LinkGeneric
01/2020
1Amyloid (Amyloid Fibrils)IBA
04/2019
1nusinersenIBA
11/2018
1Cholinesterase Inhibitors (Anticholinesterases)IBA
01/2018
1Cholinergic Agents (Cholinergics)IBA
01/2018
1Amyloid beta-PeptidesIBA
01/2018
1Levodopa (L Dopa)FDA LinkGeneric
12/2015
1Calcitonin Gene-Related PeptideIBA
09/2014
1Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)IBA
09/2014
1Histamine H3 Receptors (Histamine H3 Receptor)IBA
10/2013
1Modafinil (Provigil)FDA Link
10/2013
1Antipsychotic Agents (Antipsychotics)IBA
05/2013
1T-Type Calcium Channels (T-Type Calcium Channel)IBA
03/2013
1Olanzapine (Zyprexa)FDA Link
03/2013
1Lorazepam (Ativan)FDA LinkGeneric
02/2013
1Neurokinin-1 Receptor AntagonistsIBA
02/2013
1Pregabalin (Lyrica)FDA Link
03/2011
1Leucovorin (Folinic Acid)FDA Link
07/2010
1Folic Acid (Vitamin M)FDA LinkGeneric
07/2010
1Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
01/2010
1Interleukin-8 (Interleukin 8)IBA
04/2009
1Interleukin-6 (Interleukin 6)IBA
04/2009
1CytokinesIBA
04/2009
1EnzymesIBA
02/2007

Therapy/Procedure

11Therapeutics
01/2020 - 07/2002
2Activities of Daily Living (ADL)
01/2018 - 01/2018
2Aftercare (After-Treatment)
03/2006 - 10/2005
2Secondary Prevention
08/2004 - 07/2004
1Wearable Electronic Devices
12/2021
1Contraindications
01/2019
1Continuous Positive Airway Pressure
10/2013
1Investigational Therapies (Experimental Therapy)
03/2011